Boston Scientific(US:BSX) ZACKS·2025-12-18 00:01Company Performance - Boston Scientific (BSX) closed at $94.48, reflecting a +1.65% increase from the previous day, outperforming the S&P 500's daily loss of 1.16% [1] - Prior to this trading session, BSX shares had decreased by 6.32%, underperforming the Medical sector's gain of 1.68% and the S&P 500's gain of 1.03% [1] Earnings Projections - The upcoming EPS for Boston Scientific is projected at $0.78, indicating an 11.43% increase compared to the same quarter last year [2] - Revenue is expected to reach $5.27 billion, representing a 15.44% increase year-over-year [2] Full-Year Estimates - Full-year Zacks Consensus Estimates predict earnings of $3.04 per share and revenue of $20.06 billion, reflecting year-over-year changes of +21.12% and +19.76%, respectively [3] - Recent changes in analyst estimates suggest optimism regarding the company's business and profitability [3] Valuation Metrics - Boston Scientific has a Forward P/E ratio of 30.62, which is higher than the industry average Forward P/E of 19.24 [6] - The company holds a PEG ratio of 1.87, compared to the Medical - Products industry's average PEG ratio of 1.93 [6] Industry Context - The Medical - Products industry, part of the Medical sector, has a Zacks Industry Rank of 170, placing it in the bottom 32% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]